Abstract Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality. Although multi-kinase inhibitors can prolong the overall survival of late-stage HCC patients. the emergence of drug resistance diminishes these benefits. ultimately resulting in treatment failure. https://storeanimalwiz.shop/product-category/combs/